Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06320067 |
| Consolidated Lead Sponsor | University College, London |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 3,360 participants (ESTIMATED) |
| Registered Start Date | 2024-06-11 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University College London Hospitals NHS Foundation Trust | London, United Kingdom | Open Hospital Dossier -> |
| Barts Health NHS Trust | London, United Kingdom | Open Hospital Dossier -> |
| Royal Free Hospital | London, United Kingdom | Open Hospital Dossier -> |
| Churchill Hospital | Oxford, United Kingdom | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.